Research Analysts Set Expectations for PRAX Q4 Earnings
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Analysts at Wedbush issued their Q4 2026 earnings per share estimates for Praxis Precision Medicines in a report issued on Monday, May 5th. Wedbush analyst L. Chico forecasts that the company will post earnings of ($2.06) per share for the quarter. Wedbush has a “Underperform” rating […]
